scholarly article | Q13442814 |
P356 | DOI | 10.1158/1535-7163.MCT-05-0453 |
P698 | PubMed publication ID | 16546978 |
P50 | author | Gordon B. Mills | Q28086262 |
P2093 | author name string | Yiling Lu | |
W K Alfred Yung | |||
Shishir Shishodia | |||
Dimpy Koul | |||
Xiaoyang Sheng | |||
John F de Groot | |||
Ruijun Shen | |||
Sherry Bergh | |||
Tiffany A Lafortune | |||
P2860 | cites work | The Akt inhibitor KP372-1 suppresses Akt activity and cell proliferation and induces apoptosis in thyroid cancer cells. | Q42705524 |
P433 | issue | 3 | |
P304 | page(s) | 637-644 | |
P577 | publication date | 2006-03-01 | |
P1433 | published in | Molecular Cancer Therapeutics | Q2363144 |
P1476 | title | Inhibition of Akt survival pathway by a small-molecule inhibitor in human glioblastoma | |
P478 | volume | 5 |
Q35023915 | A novel oncolytic herpes simplex virus that synergizes with phosphoinositide 3-kinase/Akt pathway inhibitors to target glioblastoma stem cells. |
Q35757512 | A novel small molecule that selectively inhibits glioblastoma cells expressing EGFRvIII. |
Q35909804 | Akt2 knock-down reveals its contribution to human lung cancer cell proliferation, growth, motility, invasion and endothelial cell tube formation |
Q37290626 | Anti-cancer Therapies in High Grade Gliomas |
Q38696870 | Antiglioma effects of cytarabine on leptomeningeal metastasis of high-grade glioma by targeting the PI3K/Akt/mTOR pathway |
Q38911580 | Cell death pathway induced by resveratrol-bovine serum albumin nanoparticles in a human ovarian cell line |
Q48112869 | Combination of all-trans retinoic acid and interferon-gamma suppressed PI3K/Akt survival pathway in glioblastoma T98G cells whereas NF-kappaB survival signaling in glioblastoma U87MG cells for induction of apoptosis |
Q39811872 | Combination treatment with resveratrol and sulforaphane induces apoptosis in human U251 glioma cells |
Q61449553 | Correlated MRI and Ultramicroscopy (MR-UM) of Brain Tumors Reveals Vast Heterogeneity of Tumor Infiltration and Neoangiogenesis in Preclinical Models and Human Disease |
Q30008857 | Creation of an apoptin-derived peptide that interacts with SH3 domains and inhibits glioma cell migration and invasion |
Q34198939 | Current review of in vivo GBM rodent models: emphasis on the CNS-1 tumour model |
Q36755933 | DARPP32, STAT5 and STAT3 mRNA expression ratios in glioblastomas are associated with patient outcome |
Q102210924 | DNA damage induced by KP372-1 hyperactivates PARP1 and enhances lethality of pancreatic cancer cells with PARP inhibition |
Q39736362 | Effect of combination treatment of rapamycin and isoflavones on mTOR pathway in human glioblastoma (U87) cells |
Q39001865 | Exogenous endothelin-1 induces cell migration and matrix metalloproteinase expression in U251 human glioblastoma multiforme |
Q90119719 | FKBP3 mediates oxaliplatin resistance in colorectal cancer cells by regulating HDAC2 expression |
Q39532557 | Ghrelin induces cell migration through GHS-R, CaMKII, AMPK, and NF-κB signaling pathway in glioma cells |
Q33369696 | Growth inhibition and radiosensitization of glioblastoma and lung cancer cells by small interfering RNA silencing of tumor necrosis factor receptor-associated factor 2. |
Q35841656 | Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells |
Q91583495 | Involvement of Phosphatase and Tensin Homolog in Cyclin-Dependent Kinase 4/6 Inhibitor-Induced Blockade of Glioblastoma |
Q33527586 | MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol |
Q36817109 | Molecularly targeted therapies for malignant gliomas: advances and challenges |
Q36508615 | Neurokinin-1 receptor directly mediates glioma cell migration by up-regulation of matrix metalloproteinase-2 (MMP-2) and membrane type 1-matrix metalloproteinase (MT1-MMP). |
Q36344784 | Osteopontin increases heme oxygenase-1 expression and subsequently induces cell migration and invasion in glioma cells |
Q37684003 | Osthole suppresses the migratory ability of human glioblastoma multiforme cells via inhibition of focal adhesion kinase-mediated matrix metalloproteinase-13 expression |
Q47109987 | PDGFA/PDGFRα-regulated GOLM1 promotes human glioma progression through activation of AKT. |
Q37727180 | PI3K and Akt as molecular targets for cancer therapy: current clinical outcomes |
Q37808385 | PI3Kinase signaling in glioblastoma |
Q37564201 | Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy |
Q36902043 | Pediatric CNS tumors: current treatment and future directions. |
Q37444920 | Present and potential future adjuvant issues in high-grade astrocytic glioma treatment. |
Q35679353 | Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health |
Q55463435 | Shared molecular targets in pediatric gliomas and ependymomas. |
Q35593948 | SoNar, a Highly Responsive NAD+/NADH Sensor, Allows High-Throughput Metabolic Screening of Anti-tumor Agents |
Q39333861 | Suppression of EphB4 improves the inhibitory effect of mTOR shRNA on the biological behaviors of ovarian cancer cells by down-regulating Akt phosphorylation |
Q35911227 | The Akt signaling pathway: an emerging therapeutic target in malignant melanoma. |
Q33699378 | The PIK3CA gene as a mutated target for cancer therapy |
Q37454384 | The phosphoinositide 3-kinase pathway in human cancer: genetic alterations and therapeutic implications. |
Q36485266 | The sodium pump alpha1 subunit as a potential target to combat apoptosis-resistant glioblastomas |
Q38111449 | Therapeutic targeting of EGFR-activated metabolic pathways in glioblastoma |
Q39100551 | Validation of an engineered cell model for in vitro and in vivo HIF-1α evaluation by different imaging modalities. |
Q36202313 | Wogonin induces reactive oxygen species production and cell apoptosis in human glioma cancer cells |
Q35770894 | miR-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma Cells |
Search more.